Latest News

Clues beginning to emerge on asymtomatic SARS-CoV-2 infection
Back in November of 2020, during the first wave of the COVID-19 pandemic, I was teaching an in-person microbiology laboratory. One of my students had just been home to see his parents, and they all c…
Read more
Could there maybe be better uses of genetics and probiotics?
Professor Meng Dong and his laboratory have created a probiotic that can metabolize alcohol quickly and maybe prevent some of the adverse effects of alcohol consumption. The scientists cloned a highl…
Read more
ChatGPT is not the end of essays in education
The takeover of AI is upon us! AI can now take all our jobs, is the click-bait premise you hear from the news. While I cannot predict the future, I am dubious that AI will play such a dubious role in…
Read more
Fighting infections with infections
Multi-drug-resistant bacterial infections are becoming more of an issue, with 1.2 million people dying of previously treatable bacterial infections. Scientists are frantically searching for new metho…
Read more
A tale of two colleges
COVID-19 at the University of Wisconsin this fall has been pretty much a non-issue. While we are wearing masks, full in-person teaching is happening on campus. Bars, restaurants, and all other busine…
Read more

News

Insight on the Side-Effects of Antibiotics


 

Ever wondered why it's so important to take your entire antibiotic regimen? Or whether you should be worried about the plethora of medication you may be asking for, or your doctor may be prescribing? New studies show there may be more side-effects than originally anticipated.

                The dangers of anti-biotic resistance have been somewhat understood for the last twenty years. Initial concern was raised with the selective properties of drug-resistant bacteria which antibiotics seem to promote, however a new pressing concern is appearing in the degradation of human cells in over medicated persons.  The method which many antibiotics use activates the bacterial cell to lyse-or break open, through the production of toxic oxygenated species. This works with high efficiency because oxidative stress is a major concern of the cell. Allowing oxygen sub-species to remain in the cell will damage DNA, RNA and protein elements.  

            

    Scientists are now learning the side-effects of this lysing process, as the oxidative stress is observed in the tissue of humans. Specifically, the mitochondria in human cells are degrading over time, a major problem in the long term. However, it is hard to create antibiotics which do not lyse in this way, so scientists began to look for ways to reduce the stress after treatment.

                The answer came in two forms; firstly, scientists have become more successful in making antibiotics which stop reproduction of cells instead of signaling the lysis pathway. Drugs such as tetracycline target cell reproduction and stop the site of transcription, thus no oxidative structures are needed. The other solution is to immediately rid the site or cells of oxidative species as they are created. The Collins group discovered that certain molecules can be applied locally and used to ‘soak up’ the oxygen bi-product species. Anti-oxidants such as highly effective and already FDA-approved N-acetylcysteine have been shown to do just that, therefore effectively reducing the harmful effects to human tissue from antibiotics.

                While many of the side effects of antibiotics are still prevalent, scientists are beginning to more wholly understand their origins and thus solving the problem. With anti-oxidant and non-lysis drugs being developed, we are now capable of more safe and steady treatments which minimalize long term damage.